Comparison of Thrombotic Events and Mortality in Patients with Community-Acquired Pneumonia and COVID-19: A Multicenter Observational Study.
Journal
Thrombosis and haemostasis
ISSN: 2567-689X
Titre abrégé: Thromb Haemost
Pays: Germany
ID NLM: 7608063
Informations de publication
Date de publication:
02 2022
02 2022
Historique:
aheadofprint:
10
11
2021
pubmed:
11
11
2021
medline:
22
2
2022
entrez:
10
11
2021
Statut:
ppublish
Résumé
It is still unclear if patients with community-acquired pneumonia (CAP) and coronavirus disease 2019 (COVID-19) have different rate, typology, and impact of thrombosis on survival. In this multicenter observational cohort study, 1,138 patients, hospitalized for CAP ( During the in-hospital stay, 11.4% of CAP and 15.5% of COVID-19 patients experienced thrombotic events ( Compared with CAP, COVID-19 is characterized by a higher burden of thrombotic events, different thrombosis typology and higher risk of thrombosis-related in-hospital mortality.
Sections du résumé
BACKGROUND
It is still unclear if patients with community-acquired pneumonia (CAP) and coronavirus disease 2019 (COVID-19) have different rate, typology, and impact of thrombosis on survival.
METHODS
In this multicenter observational cohort study, 1,138 patients, hospitalized for CAP (
RESULTS
During the in-hospital stay, 11.4% of CAP and 15.5% of COVID-19 patients experienced thrombotic events (
CONCLUSION
Compared with CAP, COVID-19 is characterized by a higher burden of thrombotic events, different thrombosis typology and higher risk of thrombosis-related in-hospital mortality.
Types de publication
Clinical Trial
Comparative Study
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
257-266Subventions
Organisme : RM118164366B89BD
ID : Sapienza University of Rome
Informations de copyright
Thieme. All rights reserved.
Déclaration de conflit d'intérêts
None declared.